| Literature DB >> 32288268 |
Verica Aleksic Sabo1, Petar Knezevic1.
Abstract
Eucalyptus has become one of the world's most widely planted genera and E. camaldulensis (The River Red Gum) is a plantation species in many parts of the world. The plant traditional medical application indicates great antimicrobial properties, so E. camaldulensis essential oils and plant extracts have been widely examined. Essential oil of E. camaldulensis is active against many Gram positive (0.07-1.1%) and Gram negative bacteria (0.01-3.2%). The antibacterial effect is confirmed for bark and leaf extracts (conc. from 0.08 μg/mL to 200 mg/mL), with significant variations depending on extraction procedure. Eucalyptus camaldulensis essential oil and extracts are among the most active against bacteria when compared with those from other species of genus Eucalyptus. The most fungal model organisms are sensitive to 0.125-1.0% of E. camaldulensis essential oil. The extracts are active against C. albicans (0.2-200 mg/mL leaf extracts and 0.5 mg/mL bark extracts), and against various dermatophytes. Of particular importance is considerable the extracts' antiviral activity against animal and human viruses (0.1-50 μg/mL). Although the antiprotozoal activity of E. camaldulensis essential oil and extracts is in the order of magnitude of concentration several hundred mg/mL, it is considerable when taking into account current therapy cost, toxicity, and protozoal growing resistance. Some studies show that essential oils' and extracts' antimicrobial activity can be further potentiated in combinations with antibiotics (beta-lactams, fluorochinolones, aminoglycosides, polymyxins), antivirals (acyclovir), and extracts of other plants (e.g. Annona senegalensis; Psidium guajava). The present data confirm the river red gum considerable antimicrobial properties, which should be further examined with particular attention to the mechanisms of antimicrobial activity.Entities:
Keywords: Antimicrobial activity; Essential oils; Eucalyptus camaldulensis; Plant extracts
Year: 2019 PMID: 32288268 PMCID: PMC7126574 DOI: 10.1016/j.indcrop.2019.02.051
Source DB: PubMed Journal: Ind Crops Prod ISSN: 0926-6690 Impact factor: 5.645
Fig. 1Eucalyptus camaldulensis (river red gum) on the Murchison River in Western Australia (by courtesy of Prof. Stephen D. Hopper).
The main characters that distinguish Eucalyptus camaldulensis taxa.
| Taxon | Bark | Leaves | Operculum | |||
|---|---|---|---|---|---|---|
| grey-white, rough at base bark | non-glaucous, green, narrowly lanceolate juvenile leaves | strongly beaked 0.3-0.7 cm long | ||||
| essentially white, smooth and seasonally powdery bark | dull to slightly glossy green adult leaves with densely to very denselyreticulate venation | rounded or obtusely conical operculum 0.4-0.7 cm long at maturity and glaucous juvenile growth | ||||
| grey-white, smooth to base bark | ovate or lanceolate juvenile leaves, adult leaves with dense reticulation | long horn-shaped operculum 0.9–1.6 cm long | ||||
Different significant effects of Eucalyptus camaldulensis.
| Different | Model organism and/or cell line | Plant part extract, oil or compound | Effect of dosage and/or application mode | Reference |
|---|---|---|---|---|
| Gastrointestinal effect | Acetic acid induced-ulcer in rat | Leaves methanol extracts | Reduction the size from day 5 in animals treated with 500 mg/kg body weight of reconstituted extracts at 24 h interval | |
| Four ruminal fistulated buffaloes ( | Leaves meal | Dietary treatments - different levels of leaf meal supplementation at 0, 40, 80, and 120 g/hd/d for 21 days. | ||
| Protozoa count and proteolytic bacteria population were reduced (p < 0.05). Fungal spores, amylolytic, cellulolytic and total viable bacteria were unchanged. | ||||
| Anti-inflammatory and analgesic effect | Healthy albino rats (200 ± 30 g) | Seed essential oils of | Carrageenan induced paw oedema test model in rats, which received 1000 μg kg−1 body weight; 43.75-87.5% of anti-inflammatory activity | |
| Anti-nociceptive activities | Healthy albino rats (200 ± 30 g) | Seed essential oils of | Rats treated with 1000 μg kg−1 body weight, measured neurogenic and inflammatory pain responses, 41.03-99.09% of inhibition | |
| Cytotoxic effect | Two human breast cancer cell lines (MCF 7 and MDA-MB-231) | Leaves methanol, ethyl acetate, n-buthanol, and water extracts | Significant cytotoxic potential with IC50 values ranging from 3 to 250 μg/mL after 72h | |
| L20B (a genetically engineered mouse cell line) and human rhabdomyo sarcoma cells | Crude methanol extracts | Moderate cytotoxicity | ||
| Ehrlich's ascites carcinoma (EAC) in Swiss albino mice | Stem bark methanol extract | 25, 50 and 100 mg/kg/day for 5 days; High LD50 value (1120 mg/kg) | ||
| Anti-parasitic, insecticidal and repellent effects | Leaves, stem and root barks extracts | 200-600 mg/kg body weight/day of the hexane, ethyl acetate, methanol and water extracts for 21consecutive days | ||
| Promastigotes of | Methanol and aqueous extracts | IC50 values were 586.2 ± 47.6 and 1108.6 ± 51.9 μg/mL | ||
| Larvicidal activity against | Leaves extract and volatile oil | LC50 values of 89.85 and 397.75 ppm, respectively. Clear dose-response relationships, the highest dose of 320 ppm essential oil extract resulted almost in 100% mortality in the population after 24 h of exposure | ||
| Mosquito larvicidal against two mosquito species, | Leaves essential oils and their 12 constituents | 400, 200, 100, 50, and 25 μg/mL of essential oil were tested and each compound was tested at 50, 25, 12.5, and 6.25 μg/mL; Mortality was recorded after 24 h; LC50 values 31.0-55.3 lg/mL, LC90 values 71.8-192.4 lg/mL. | ||
| Essential oil | LC50values 2.28 μl L−1air | |||
| Repellency against the adult females of | Dried fruits essential oil | Two different treatment levels (5 and 10 μl) in six exposure times (15, 75, 135, 195, 255 and 315 s) | ||
| Anti-diabetic effect | Albino rats | Leaves ethanol extract | Oral 500 mg/kg of body weight | |
| Alloxan-induced diabetic rats | Leaves ethanol extract | 500 mg/kg of body weight in distilled water orally, | ||
Classes of major Euclyptus camaldulensis essential oils compounds and their content in different plant parts.
| Chemical classes | Chemical subclasses | Sublaclasses content in leaf and fruit (%) | Major essential oils compounds | Major compounds content in oil | ||
|---|---|---|---|---|---|---|
| L | Fr | Fl | ||||
| Terpenes | Monoterpene hydrocarbons | 5.7-52.2 L | α-Pinene | 1.7-28.3 | 1.12-3 | 3.51 |
| 18.7 Fr | β-Pinene | 0.3-18.6 | 8.8 | 7.7-27.09 | ||
| 18.5 Fl | α-Thujene | 1.0-3.4 | 0.3 | 0.6-0.77 | ||
| β-Phellandrene | 0.5-7.5 | 0.3 | 2.1-2.2 | |||
| p-Cymene | tr. -6.5 | 4.8 | 9.32 | |||
| γ-Terpinene | 0.19-7.6 | 0.2 | 0.4-0.5 | |||
| Sesquiterpene hydrocarbons | 1.8-3.6 L | Aromadendrene | 0.1-11 | 0.2 | 0.21-0.24 | |
| 6.1 Fr | 0.2-1 | 3 | 0.2 | |||
| 1.2 F•l | Bicyclogermacrene | 0.3-1.8 | 2 | 0.09-0.4 | ||
| α-Copaene | 0.9 | tr. | – | |||
| Terpenoids | Oxygenated monoterpenes | 40.8-87.42 L | 1,8-Cineole | 13.73-84.9 | 3.8 | 34.7-69.26 |
| 14.1 Fr | 0.06-8.5 | 0.2 | 0.11-1.9 | |||
| 50 Fl | Terpinen-4-ol | 0.27-5.2 | 1.9 | 3.29-3.6 | ||
| Myrtenol | 1.4-9.75 | 2.1 | 0.12 | |||
| Cuminal | 0.09-3.2 | 1.3 | 0.94-1.01 | |||
| Oxygenated sesquiterpenes | 4.9-39.6 L | Spathulenol | 0.16-19.2 | 19 | 0.12-10.18 | |
| 23.2 Fr | Elemol | 0.6-3 | – | – | ||
| 12.7 Fl | β-Eudesmol | 0.13-4.4 | – | – | ||
| 0.9-5 | – | 0.1 | ||||
L- leaf, Fr-fruit, Fl-flower.
tr., traces (<0.05%).
Antimicrobial activity of E. camaldulensis essential oils and extracts.
| Microorganism | Activity | Recalculated (%) | References | ||||||
|---|---|---|---|---|---|---|---|---|---|
| MIC | MBC | MIC | MBC | ||||||
| Essential oil | Leaves essential oil (%, v/v) from Northern Cyprus | 0.5 | |||||||
| >1 | |||||||||
| Leaves essential oil (μg/mL) from Iran | 8 | 0.0008 | |||||||
| Leaves essential oil (μg/mL) from Iran | 3.9 | 3.9-7.8 | 0.00039 | 0.00039– 0.00078 | Panahi et al. (2011) | ||||
| Leaves essential oil (μL/mL) from Ethiopia | 2.5–5.0 | 0.27–0.53 | |||||||
| 5.0 | 0.53 | ||||||||
| 2.5 | 0.27 | ||||||||
| 5.0 | 0.53 | ||||||||
| Essential oil (μg/mL) from Iran | 64 | 128 | 0.0064 | 0.0128 | |||||
| Leaves essential oil (%) from Iran | 0.1 | 0.2 | |||||||
| 0.15 | 0.25 | ||||||||
| 0.25 | 0.35 | ||||||||
| 0.30 | 0.45 | ||||||||
| 0.2 | 0.40 | ||||||||
| 0.05 | 0.15 | ||||||||
| 0.4 | 0.6 | ||||||||
| 0.35 | 0.45 | ||||||||
| 0.6 | 0.8 | ||||||||
| Leaves essential oil (mg mL-1) from Iran | 1 | 2 | 0.1 | 0.2 | |||||
| Leaves essential oil (mg mL-1) from Thailand | 5 | 0.5 | |||||||
| 10 | 1 | ||||||||
| >10 | >1 | ||||||||
| Leaves essential oil (μl mL-1) from Montenegro | Reference | 0.5–1 | 0.7–4 | 0.05–0.1 | 0.07–0. 4 | ||||
| 1 | 1–2 | 0. 1 | 0.1–0.2 | ||||||
| Leaves essential oil (μl/mL) from Kenya | 7–8 | 8–10 | 0.7–0.85 | 0.85–1 | |||||
| Leaves essential oil (μl/mL) from Algeria | 2.5 | 0.27 | |||||||
| 1.25 | 0.13 | ||||||||
| Leaves essential oil (μg mL-1) from Brazil | 1000 | 0.1 | |||||||
| >1000 | >0.1 | ||||||||
| Leaves essential oil from Egypt | % of reduction | ||||||||
| Rotavirus Wa strain | 50 | ||||||||
| Coxsackievirus B4 | 53.3 | ||||||||
| Herpes virus type 1 | 90 | ||||||||
| Adenovirus type 7 | 0 | ||||||||
| EOs in vegetable oil (mg/mL) | Trypanosoma brucei brucei and Trypanosoma evansi | 100 | 10 | ||||||
| Leaves essential oil (mg/mL) from Syria | 0.2 | 0.8 | 0.02 | 0.8 | |||||
| 1.6–3.2 | 1.6–3.2 | 0.16–0.32 | 0.16–0.32 | ||||||
| 0.2–0.4 | 0.4–1.6 | 0.02–0.04 | 0.04–0.16 | ||||||
| 0.4–0.8 | 0.8–1.6 | 0.04–0.08 | 0.08–0.16 | ||||||
| 1.6–3.2 | 3.2 | 0.16–0.32 | 0.32 | ||||||
| 0.1 | 0.2 | 0.01 | 0.02 | ||||||
| 1.6–3.2 | 3.2 | 0.16–0.32 | 0.32 | ||||||
| 0.4–3.2 | 0.8–3.2 | 0.04–0.32 | 0.08–0.32 | ||||||
| >12.8 | >12.8 | >1.28 | >1.28 | ||||||
| Leaves essential oil from Iran | GI | ||||||||
| 100% | |||||||||
| 0% | |||||||||
| Plant extract | Leaves acetone extract (mg/l) from Nigeria | MDR | 20–50 | 0.002–0.005 | |||||
| Leaves methanol extract (mg/mL) from Egypt | MDR | 0.78 | 0.078 | ||||||
| MDR | 3.12 | 0.312 | |||||||
| Bark butanol extract (μg mL-1) from Egypt | 16 | 0.0016 | |||||||
| 125 | 0.0125 | ||||||||
| 250 | 0.025 | ||||||||
| 500 | 0.05 | ||||||||
| Leaves methanol extracts (mg/mL) from India | 5 | 0.5 | |||||||
| 10 | 1.0 | ||||||||
| 25 | 2.5 | ||||||||
| 50 | 5.0 | ||||||||
| 75 | 7.5 | ||||||||
| Leaves crude methanolic extracts (μg mL-1) from Egypt | 0.08 | 0.16 | 0.000008 | 0.000016 | |||||
| 0.22 | 0.40 | 0.000022 | 0.00004 | ||||||
| Leaves methanol, ethanol, and petroleum ether extracts (mg mL-1) from Nigeria | 100 | 200 | 10 | 20 | |||||
| 50–200 | 200–400 | 5–20 | 20-40 | ||||||
| 50–200 | 100–200 | 5–20 | 10–20 | ||||||
| 50–100 | 50–400 | 5–10 | 5–40 | ||||||
| 50–200 | 50–200 | 5–20 | 5–20 | ||||||
| Leaves methanol–dichloromethane extracts (mg mL-1) from Japan | 0.063 | 0.0063 | |||||||
| 0.125 | 0.0125 | ||||||||
| >0.250 | >0.0250 | ||||||||
| Leaves crude methanol extracts (μg mL-1) from Nigeria | 200 | 0.02 | |||||||
| >200 | >0.02 | ||||||||
| Leaves methanol extract (mg mL-1) from Nigeria | 10 | 1.0 | |||||||
| Leaves dichloromethane fraction (mg mL-1) from Nigeria | 1.25 | 0.125 | |||||||
| 0.157 | 0.0157 | ||||||||
| 0.04 | 0.004 | ||||||||
| 10 | 1.0 | ||||||||
| 0.625 | 0.0625 | ||||||||
| 0.79 | 0.079 | ||||||||
| Leaves crude n-hexane extracts; crude chloroform leaves and steam extracts (μg mL-1) from Nigeria | <25 | <0.0025 | |||||||
| Steam crude n-hexane extracts (μg mL-1) from Nigeria | <12.5 | <0.00125 | |||||||
| Leaves and steam bark hexane, chloroform, methanol extracts (μg/mL) from Nigeria | 4–52.2 | 0.0004–0.0064 | |||||||
| Leaves methanol extracts 80% (μg/mL) from Ethiopia | 6.25–50 | 0.000625–0.005 | |||||||
| 12.5–50 | 0.00125–0.005 | ||||||||
| Leaves crude water extracts (mg/mL) from Nigeria | 50 | 5.0 | |||||||
| Leaves crude ethanol extracts (mg/mL) from Nigeria | 25 | 2.5 | |||||||
| Leaves crude acetone extracts (mg/mL) from Nigeria | 50 | 5.0 | |||||||
| 25 | 2.5 | ||||||||
| 15 | 1.5 | ||||||||
| 25 | 2.5 | ||||||||
| 15 | 1.5 | ||||||||
| Leaves essential oil (mg/mL) from Egipt | 0.7 | 0.07 | |||||||
| 3.12 | 0.312 | ||||||||
| Leaves DMSO extract (μg/mL) from Jordan | Newcastle Disease Virus (NDV) | 50-500 | 0.005-0.05 | ||||||
| Leaves methanol extract (μg/mL) from Israel | IC50 | IC50 | |||||||
| Herpes simplex virus -1 | 0.1±0.08 0.3±0.02 | 0.00001±0.000008 | |||||||
| Herpes simplex virus -2 | 1±0.03 | 0.00003±0.000002 | |||||||
| Varicella-Zoster Virus | 0.0001±0.000003 | ||||||||
| Leaves methanol extracts from Nigeria | Poliovirus type I | neutralization index of one log and above | |||||||
| Coxsackievirus B | |||||||||
| Echovirus 6 | |||||||||
| Bark n-butanol extract (μg /mL) from Egypt | 16 | 0.0016 | |||||||
| 125 | 0.0125 | ||||||||
| 250 | 0.025 | ||||||||
| 500 | 0.05 | ||||||||
| Leaves methanol extracts (mg/mL) from Iran | 0.8 | 6.4 | 0.08 | 0.64 | |||||
| 1.6 | 3.2 | 0.16 | 0.32 | ||||||
| 1.6 | 1.6 | 0.16 | 0.16 | ||||||
| 0.4 | 0.8 | 0.04 | 0.08 | ||||||
| 0.2 | 0.8 | 0.02 | 0.08 | ||||||
| 0.2 | 0.8 | 0.02 | 0.08 | ||||||
| Bark dichloromethane: methanol extract; aqueous extract (mg/mL) from South Africa | MICD:M | MICAQ | MICD:M | MICAQ | |||||
| 0.25–1.0 | 0.5–0.63 | 0.025–0.1 | 0.05–0.063 | ||||||
| 0.5 | 2.0 | 0.05 | 0.2 | ||||||
| 2.0 | 4.0 | 0.2 | 0.4 | ||||||
| 0.5 | 2.0 | 0.05 | 0.2 | ||||||
| 0.25 | 0.20 | 0.025 | 0.02 | ||||||
| 0.10 | 2.0 | 0.01 | 0.2 | ||||||
| 1.0 | 1.0 | 0.1 | 0.1 | ||||||
| 4.0 | 2.0 | 0.4 | 0.2 | ||||||
| Leaves methanol and aqueous extracts (μg/mL) from Iran | IC50 | IC50 | |||||||
| 586.2-1108.6 | 0.05862–0.11086 | ||||||||
| Leaves crude, diethyl ether, ethyl acetate, aqueous (mg/mL) from Iran | 100% growth inhibition with 12.5–50; 24–72 h | 100% growth inhibition with 1.25–5%; 24–72 h | |||||||
| Leaves wather and ethanolic extracts (μg/mL) from Iran | Dead for 72 h with 60-90 | Dead for 72 h with 0.006–0.009% | |||||||
| Leaves aqueous extract (mg/mL) from Iraq | Dead for 24 h with 500 | Dead for 24 h with 50% | |||||||
MIC – minimal inhibitory concentration, MBC – minimal bactericidal concentration, GI – growth inhibition, IC50 - 50% inhibitory concentration.
Fig. 2Schematic diagram for re-calculation from microliter or milligram per milliliter to percentage (v/v or w/v).
Effects of Eucalyptus camaldulensis and other antimicrobial agents in combination.
| Antimicrobial agent(s) in combination | Test organism | Method | Effect of combination | Reference | |
|---|---|---|---|---|---|
| Leaf essential oils from Montenegro | Ciprofloxacin, Gentamicin, Polymyxin B | Reference | Two-dimensional checkerboard method ( | Synergism (FICI ≤ 0.5) | |
| Leaf essential oil from Brazil | Cephalexin | The MIC of the antibiotics were determined in the presence and absence of sub-inhibitory concentrations (125 μg mL−1) of the essential oil ( | Combining the essential oil with β-lactams reduced the resistance of tested strains | ||
| Cefuroxime | |||||
| Amoxicillin | |||||
| Ampicillin | |||||
| Leaf methanol extract (0.01 μg/mL) from Israel | Acyclovir (0.01 μg/mL) | Treating the cells with different combinations of the extract and acyclovir at the time and post-infection with the virus | Significant inhibition (˜75%) of the viral infection, comparing to single agent (10-20%) | ||
| Leaf methanol extract from Nigeria | Leaf methanol extracts of | 200 mg/kg bodyweight/day (for 21 days) of crude methanol extracts of | Synergism (only the combination 1:1 resulted in the complete clearance of parasites from the circulation of animal) | ||
| Leaf methanol extract from Egypt | Gentamicin, Ceftriaxone | MDR | Synergism | ||
| MDR | |||||
| Leaf acetone extract from Nigeria | Ampicillin | MDR S. aureus | Synergism | ||
| Ciprofloxacin | |||||
| Leaf ethanol extract from Nigeria | Agar disc diffusion method was employed as described by | Synergism | |||
| MDR |